NANETTI, ANNA
NANETTI, ANNA
DIPARTIMENTO DI EMATOLOGIA E SCIENZE ONCOLOGICHE "L. e A. SERAGNOLI"
An active microbiological survillance project at an Italian teaching Hospital: microbial isolates, recent epidemiological trends, major clinical concerns, and antimicrobial susceptibility rates during a four-year period
2009 R. Manfredi; A. Nanetti
Escherichia coli and other Enterobacteriaceae. Antimicrobial susceptibility trends in a four-year prospective surveillance hospital monitoring
2009 R. Manfredi; A. Nanetti
In vitro antimicrobial sensitivity trends of Enterococci isolated at an Italian teaching hospital. A 2004-2007 prospective report including over 2,700 examined microbial strains
2009 R. Manfredi; A. Nanetti
Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological, and imaging response of lung tuberculosis to specific treatment. Which role for linezolid?
2009 R. Manfredi; A. Nanetti; P. Dal Monte; L. Calza
MIcroorganisms isolated from blood cultures in a 2004-2007 prospective observational study
2008 R. Manfredi; A. Nanetti
Unexpectedly slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. A possible pathomorphism of pulmonary tuberculosis?
2008 R. Manfredi; A. Nanetti; P. Dal Monte; G. Battista; C. Sassi; L. Miglio; F. Toni; B. Piergentili; L. Calza
Ceramic surfaces with microbiological action for healthcare buildings
2007 A. Tucci; A. Nanetti; L. Malmusi; G. Timellini
Prospective microbiological surveillance in a teaching Hospital of Northern Italy. Microbial isolations and antimicrobial susceptibility levels, and related concerns
2007 A. Nanetti; R. Manfredi
Superficies Cerâmicas com ação microbiologica para ambientes hospitalares
2007 A. Tucci; A. Nanetti; L. Malmusi; G. Timellini
Tubercolosi "extensively drug resistant" (XDR) in pazienti recentemente immigrati dal Paesi dell'Est Europeo. Aspetti microbiologici e terapeutici, ruolo dei farmaci di seconda scelta, e problematiche gestionali e di Sanità Pubblica
2007 R. Manfredi; S. Sabbatani; L. Attard; G. Marinacci; G. Bocchi; C. Violante; G. Salvucci; P. Fiacchi; P. Dal Monte; A. Nanetti
A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone
2006 R. Manfredi; S. Sabbatani; A. Nanetti; F. Chiodo
Role of isolation of Corynebacterium spp. organisms in different clinical settings, including intensive care units
2006 R. Manfredi; A. Nanetti; S. Morelli; R. Valentini; L. Calza; F. Chiodo
A 2-year survey of bacteriologic profile and antimicrobial susceptibility levels of Enterococci in a large Italian teaching hospital.
2004 R. Manfredi; A. Nanetti; R. Valentini; S. Morelli; L. Calza
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection.
2004 R. Manfredi; A. Nanetti; S. Morelli; M. Ferri; R. Valentini; L. Calza; F. Chiodo
Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study.
2004 R. Manfredi; A. Nanetti; R. Valentini; M. Ferri; S. Morelli; L. Calza
Methicillin-resistant staphylococci still susceptible to non-beta-lactam antibiotics. What clinical implications in nosocomially-acquired infections?
2004 R. Manfredi; A. Nanetti; R. Valentini; S. Morelli; S. Sabbatani; L. Calza; F. Chiodo
Sensitivity of methicillin-resistant Staphylococcus aureus (MRSA) to antimicrobial agents other than beta-lactams: profile and trend, 1998-2003
2004 R. Manfredi; A. Nanetti; S. Morelli; R. Valentini; L. Calza; F. Chiodo